ML 315

• Description :

  ML 315 is a selective Clk and DYRK inhibitor with potential anticancer activity for the study of neurological disorders.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  374.22

• Molecular Formula :

  C18H13Cl2N3O2

• Notes :

  Research use only, not for human use.

• Receptor :

  DYRK | CDK

• CAS Number :

  1440251-53-5